Skip to Content

335 (Pyridostigmine Bromide Extended-Release 180 mg)

Pill with imprint 335 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Alvogen, Inc..

Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 335

Pyridostigmine Bromide Extended-Release

Imprint:
335
Strength:
180 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinergic muscle stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alvogen, Inc.
National Drug Code (NDC):
47781-0335

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide